- Home
- HBI vs APGE Comparison
HBI vs APGE Comparison
Compare HBI & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBI
- APGE
- Stock Information
- Founded
- HBI 1901
- APGE 2022
- Country
- HBI United States
- APGE United States
- Employees
- HBI N/A
- APGE N/A
- Industry
- HBI Clothing/Shoe/Accessory Stores
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HBI Consumer Discretionary
- APGE Health Care
- Exchange
- HBI Nasdaq
- APGE Nasdaq
- Market Cap
- HBI 1.9B
- APGE 2.1B
- IPO Year
- HBI 2006
- APGE 2023
- Fundamental
- Price
- HBI $4.56
- APGE $43.59
- Analyst Decision
- HBI Hold
- APGE Strong Buy
- Analyst Count
- HBI 4
- APGE 4
- Target Price
- HBI $5.75
- APGE $91.33
- AVG Volume (30 Days)
- HBI 4.2M
- APGE 872.0K
- Earning Date
- HBI 08-07-2025
- APGE 08-11-2025
- Dividend Yield
- HBI N/A
- APGE N/A
- EPS Growth
- HBI N/A
- APGE N/A
- EPS
- HBI N/A
- APGE N/A
- Revenue
- HBI $3,522,911,000.00
- APGE N/A
- Revenue This Year
- HBI $0.50
- APGE N/A
- Revenue Next Year
- HBI N/A
- APGE $743.14
- P/E Ratio
- HBI N/A
- APGE N/A
- Revenue Growth
- HBI 0.65
- APGE N/A
- 52 Week Low
- HBI $4.02
- APGE $26.20
- 52 Week High
- HBI $9.10
- APGE $63.50
- Technical
- Relative Strength Index (RSI)
- HBI 43.17
- APGE 58.77
- Support Level
- HBI $4.26
- APGE $40.24
- Resistance Level
- HBI $4.71
- APGE $44.61
- Average True Range (ATR)
- HBI 0.14
- APGE 2.41
- MACD
- HBI -0.02
- APGE 0.12
- Stochastic Oscillator
- HBI 41.07
- APGE 74.41
About HBI Hanesbrands Inc.
Hanesbrands manufactures basic and athletic apparel under brands including Hanes, Playtex, Maidenform, Bali, Berlei, and Bonds. The company sells wholesale to discount, midmarket, and department store retailers as well as direct to consumers through stores and e-commerce. Hanesbrands is vertically integrated as it produces nearly 75% of its products in company-controlled factories in more than three dozen nations. Hanesbrands distributes products in the Americas and Asia-Pacific. The company was founded in 1901 and is based in Winston-Salem, North Carolina.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.